Brief: Brazil's Blau enters partnership with JSR to develop highly complex biotechnological drugs
Oct 25 (Reuters) - Blau Farmaceutica SA BLAU3.SA :
* BRAZIL'S BLAU: ENTERS PARTNERSHIP WITH JSR LIFE SCIENCES
GROUP
TO DEVELOP HIGHLY COMPLEX BIOTECHNOLOGICAL DRUGS
* BRAZIL'S BLAU: ESTIMATES THAT TOTAL INVESTMENT IN THE
PROJECT
COULD EXCEED $100 MILLION OVER THE NEXT 10 YEARS
Source text for Eikon: ID:nBVSBhv3Ca
Further company coverage: BLAU3.SA
(Reporting by Sao Paulo newsroom)
((Gabriel.Araujo2@thomsonreuters.com;))
Recent news on JSR
See all newsBrief: Entegris Inc: Entered Into Non-Exclusive Cross-Licensing To EUV Lithography With JSR Corp
Brief: JSR Says Tetsuro Hori To Become CEO From April 1
Brief: Jsr Corp - To Be Delisted From Tokyo Stock Exchange As Of June 25
Brief: JSR Corp - To Retire Treasury Shares Worth 0.37% Of Outstanding Stock On June 26
Table: JSR -2023/24 parent results